Le Lézard
Classified in: Health
Subjects: CALENDAR OF EVENTS, HEALTH, TRADE SHOWS/SEMINARS/WEBINARS

Premier Health Announces Attendance at AlphaNorth Capital Investment Conference


VANCOUVER, British Columbia, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Premier Health Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the "Company" or "Premier Health"), a company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the healthcare industry, is pleased to announce it will be participating in the Alpha North Capital Investment Conference at the Grand Hyatt Baha Mar in the Bahamas from January 17 ? 19, 2020.

The conference introduces growth-stage companies across various sectors including technology, biotech and healthcare to top institutions and specialist brokers in North America through a full day series of one-on-one meetings between issuers and investors.

"We are excited to attend the AlphaNorth Conference for a second year in a row to communicate the progress on our story to Canadian, US and international investors providing them the opportunity to hear firsthand of our successes to date and growth plans moving forward," said Dr. Essam Hamza, CEO of Premier Health.

The company would also like to announce that it has also updated their corporate presentation for 2020. The presentation can be found at: https://www.mypremierhealth.com/wp-content/uploads/2020/01/PHGI-2020-01-09.pdf.

ON BEHALF OF THE BOARD OF DIRECTORS

"Dr. Essam Hamza, MD"
Chief Executive Officer                                                                                                             

About Premier Health

Premier Health is a Canadian company that is strategically poised to take advantage of business opportunities in the global health care industry. We are focused on innovative health care approaches that combine human skill-based expertise with emerging technologies. In conjunction with its subsidiary Cloud Practice, which offers SAAS based health technology solutions including a cloud based Electronic Medical Records (EMR) software, medical billing software and an online patient portal, the Company is developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics, telemedicine, and artificial intelligence (AI). We currently have a combined ecosystem of 315 clinics, over 3000 licensed practitioners and almost 3 million registered patients. The Company recently acquired Livecare, a pioneer in telehealth and a key enabler for sustainable health in geographically disperse populations. The Premier Health team has deep clinical, operational and financial expertise and a passion for improving healthcare for all patients.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

FOR ADDITIONAL INFORMATION CONTACT:

Premier Health Group Inc.
www.mypremierhealth.com
Email: [email protected]

Renmark Financial Communications Inc.
Bettina Filippone: [email protected]
Tel:(416) 644-2020 or (514) 939-3989
www.renmarkfinancial.com


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: